SCHEMBL312964

SCHEMBL312964

CCOC(=O)Nc1cc(O)c(F)cc1-c1cc(=O)c2ccc(F)cc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
THRB P10828 1/20 0.43
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
KCNQ3 O43525 2/20 0.38
KCNQ2 O43526 2/20 0.38
NPC1 O15118 1/20 0.38
KCNQ4 P56696 1/20 0.38
KCNQ5 Q9NR82 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
ABL1 P00519 1/20 0.38
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312712 0.89 HPGD (0.43) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL311994 0.87 KMT2A (0.46) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL311700 0.84 ALDH1A1 (0.41) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL312527 0.83 MEN1 (0.46) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL311335 0.82 NLRP3 (0.40) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL313232 0.81 HPGD (0.46) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL312241 0.79 ALDH1A1 (0.43) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL312016 0.79 HPGD (0.51) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL311421 0.78 MEN1 (0.42) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL312303 0.76 TUBB4A (0.40) MEN1KMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed